Home Depot Comparable Sales Match Lowes Signaling Potential Stock Performance Shift DeepSeek Chinese AI Model Earns Silicon Valley Praise Despite Chip Hurdles Jim Hensons Creature Shop Opens to Public After Decades of Secrecy US Jobs Report Faces Another Delay Amid Ongoing Government Shutdown Nvidias Annual Spending on Taiwan AI Suppliers Could Reach 150 Billion Says CEO Jensen Huang Neelkanth Mishra Sees Meaningful Rate Cuts Ahead Repo Rate May Hit Decade Low LBTYK Q1 2026 Earnings Massive EPS Beat Signals Strong Profitability Shift ICFI Q1 2026 Earnings EPS Misses Estimates Stock Rises Slightly CSX Q1 2026 Earnings EPS Surprise Drives Profit Beat but Stock Declines TG Therapeutics Q1 2026 Earnings EPS Misses Expectations Despite Stock Gain NRG Q1 2026 Earnings EPS Misses Expectations Amid Mixed Performance MGRC Q1 2026 Earnings EPS Falls Short of Estimates Shares Inch Higher Mesabi Trust MSB Declines Amid Broader Commodity Pressures Key Support Levels in Focus Occidental Petroleum OXY Drops 163 Key Support and Resistance Levels in Focus Federated Hermes FHI Gains 176 as Stock Tests Key Resistance Levels Natural Grocers NGVC Slightly Declines Amidst Sector Headwinds Eyes Key Support Aurora Innovation Warrants AUROW Slide 109 as Resistance Caps Recovery at 042 US Nonfarm Payrolls Surge Past Expectations Yet Report Flags Economic Concerns The Lovesac Company LOVE Q1 2026 Earnings EPS Surges Past Estimates Stock Gains Modestly Cognex Corporation CGNX Rallies Over 3 as Shares Bounce From Key Support Perpetua Resources Secures 29 Billion US Loan for Idaho Critical Minerals Project Fatal Train Attack in Pakistan Could Heighten Security Risks for Regional Markets Historic UKGCC Trade Deal Set to Add Billions to British Economy UK Bank Holiday Travel Chaos and Record Heat Implications for Travel and Retail Sectors Oil Stock Poised to Outperform Despite Potential Iran Deal Easing Energy Markets UnitedHealth Group UNH Appears Among Top Hedge Fund Dividend Picks Amid Analyst Optimism Regeneron and Parabilis Medicines Forge 232 Billion Deal to Target Undruggable Proteins